Kenox Pharmaceuticals, Inc的动态

Kick off of the #FT and #Endpointsnews Pharma & biotech summit with a panel discussion on the impact of the US election results on US healthcare in terms of drug policy & drug pricing led by Ian Johnson global FT pharma correspondent , together with Drew Armstrong, Exec editor #EndpointsNews & Oliver Barnes #FT US Pharma & biotech correspondent . The panellists agreed we can clearly expect a squeeze on US drug pricing . No doubt a big boost for the #biosimilar market

This is a very important topic with industry leaders and influencers. Send me a message if you want more information. See you there! #DIA2024 #ICH #Data #RegulatoryOperations

Biocon Biologics will be at?SIFO Farmacia Ospedaliera’s National Congress with Giovanni Carubia Country Manager - Italy. We look forward to engaging with the scientific community and discussing new solutions to make Italy’s pharmaceutical supply to the Healthcare System even more effective. ? Come visit us at our booth no. 65 to learn more about Biocon Biologics’ commitment to guaranteeing access to essential treatments in Italy through #biosimilars, and how we contribute to a more resilient and sustainable health system. ? #CongressoSIFO2024 #BioconBiologicsEurope

Excited to share that I'll be speaking at the upcoming CompLaw Pharma conference on December 3rd! Our panel will be discussing Art. 102 and recent updates. Looking forward to engaging with fellow colleagues and sharing insights on the latest developments in our industry. Come and join us! #Pharma @Informa @competitionlaw

This an interesting read. Of particular relevance to me - skills shortages continue to be a concern for the industry, and so it's more important than ever that organisations consider not just their talent acquisitions strategies, but also talent retention and succession planning

Webinars are everywhere these days, but I promise you this one’s worth it! ?? ?? ?? Thermo Fisher Scientific is hosting an exclusive session that explores an innovative solution—integrating our practical strategies for simplifying the development journey with our Accelerator? Drug Development providing CDMO and CRO efforts under one seamless umbrella. This is your opportunity to discover how to streamline operations, enhance quality, and achieve milestones faster than ever before! ?? ?? ?? During this webinar, we will share key insights from preliminary findings by the TUFTS Center for the Study of Drug Development. We will delve into how a comprehensive model that unites CDMO and CRO services which can significantly impact the expected Net Present Value (eNPV) of drug development programs. Don't miss out on this chance to see how we're revolutionizing the industry. Feel free to DM me for more details or any questions on how we can help you succeed! ???? Click here to tune in ??! https://lnkd.in/ecVDtWhD #Webinar #DrugDevelopment #ThermoFisher #CDMO #CRO #Biotech #ClinicalResearch #DrugDiscovery #LifeSciences #PharmaSuccess #PharmaWebinar

Ending Unethical Pharma Practices_A Call for Action|Top PharmaHealth News for 27.12.24 https://lnkd.in/g7yZjzUY TN Govt to Expand B Pharm and M Pharm Colleges. Panel Urges Govt to Boost Support for Fermentation-based API Manufacturing to reduce China Import Alleged UCPMP Violation. Mankind Pharma to Market Innovent Biologics' PD-1 Inhibitor Sintilimab for Cancer Treatment in India. Some fresh USFDA approvals and more. Stay informed on these critical updates shaping the pharmaceutical and healthcare industries! Subscribe for daily pharmahealth news and insights. ??

You’ve probably heard the stat — 90% of all clinical drug trials fail. At American Injectables, we don’t think it's audacious to change that. When you’re out of the loop, it’s easy for other CDMOs to rush development and then blame bad chances. Partner with a CDMO that will be diligent and transparent at every stage. #Formulation #FormulationDevelopment #AmericanInjectables #Pharma #CDMO #Transparency

???? Fluart Shines at the 35th CPHI in Milan! ???? Fluart was proud to participate in the 35th CPHI, held this year in the vibrant city of Milan. This global event highlighted the critical role of CDMO services in driving pharmaceutical innovation. The groundbreaking advancements showcased at CPHI reinforced a key takeaway: the pharma industry’s rapid innovation wouldn’t be possible without the support and expertise provided by CDMOs like Fluart. ?? From cutting-edge drug development to seamless manufacturing solutions, CDMOs are essential in ensuring that life-changing medicines reach the market efficiently and safely. We’re excited to continue leading the charge in this evolving landscape, bringing top-tier solutions to our partners around the world. https://lnkd.in/e6BeVrHw Let’s shape the future of healthcare together! ???? #Fluart #CPHI2024 #PharmaInnovation #CDMOServices #DrugDevelopment #PharmaceuticalExcellence #HealthcareInnovation #Biotech #PharmaManufacturing #LifeSciences #GlobalPharma

Let our AI integration help determine what intervention strategy is the most effective for your patient population and demonstrate the value of applying that strategy, both for health outcomes AND cost savings ...